Altered Aortic Production of 6-Keto-Prostaglandin F1αfrom Aldosterone-Salt Hypertensive Rats
- 1 January 1992
- journal article
- research article
- Published by S. Karger AG in Journal of Vascular Research
- Vol. 29 (3) , 256-263
- https://doi.org/10.1159/000158940
Abstract
Supersensitivity of vascular smooth muscle to catecholamines in aldosterone-salt hypertensive rats appears to reside beyond the α1-adrenoceptor. The objective of this study was to assess the norepinephrine-stimulated production of arachidonic acid metabolites by aorta from control-salt rats (CSR) and aldosterone-salt hypertensive rats (AHR) to determine whether these metabolites might contribute to the altered sensitivity. Norepinephrine increased in a time-dependent manner the production of 6-keto-prostaglandin F α1 (6-keto-PGF α1), thromboxane B2 (TXB2) and prostaglandin E2 (PGE2) by the aortae of CSR. Production was an α1-adrenoceptor-mediated event since it was inhibited greatly by prazosin but not by yohimbine. Basal values of the metabolites did not differ for 6-keto-PGF α1 and TXB2, but were higher in AHR compared with CSR for PGE2. The norepinephrine concentration-response curve for 6-keto-PGF α1 was shifted significantly to the right for the AHR group compared with CSR (EC50 = 2.30 + 0.55 and 0.29 ± 0.07 µM, respectively) indicating decreased production of norepinephrine-stimulated prostaglandin I2 in AHR. The norepinephrine-stimulated TXB2 concentration-response curves for AHR and CSR were similar. Indomethacin was an effective inhibitor of TXB2 and 6-keto-PGF 1α production in both. Norepinephrine-stimulated contraction was significantly affected by indomethacin in CSR but not in AHR. Whereas we observed an attenuation of a norepinephrine-stimulated vasodilatory substance in aortae of AHR compared with CSR, the effect of attenuation on vascular activity is presently unclear.Keywords
This publication has 0 references indexed in Scilit: